Anne Bruun Rovsing

Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and <i>in vivo</i> gene modification

Jakob Haldrup, Sofie Andersen, Alexander Rafael LaVilla Labial et al. · Nucleic Acids Research · 2023 · 52 citations · Full text

Engineering, In Vivo Gene Therapy, Molecular Biology +20

Identification of BLNK and BTK as mediators of rituximab‐induced programmed cell death by CRISPR screens in GCB‐subtype diffuse large B‐cell lymphoma

Emil Aagaard Thomsen, Anne Bruun Rovsing, Mads Valdemar Anderson et al. · Molecular Oncology · 2020 · 20 citations · Full text

Immunology, Pathology, Cell Death +17

Resistance to vincristine in <scp>DLBCL</scp> by disruption of p53‐induced cell cycle arrest and apoptosis mediated by <scp>KIF18B</scp> and <scp>USP28</scp>

Anne Bruun Rovsing, Emil Aagaard Thomsen, Ian Helstrup Nielsen et al. · British Journal of Haematology · 2023 · 13 citations · Full text

Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles

Ian Helstrup Nielsen, Anne Bruun Rovsing, Jacob Hørlück Janns et al. · Molecular Therapy — Nucleic Acids · 2024 · 10 citations · Full text